Cargando…

Heterogeneity of cortical pTDP-43 inclusion morphologies in amyotrophic lateral sclerosis

BACKGROUND: Despite the presence of significant cortical pTDP-43 inclusions of heterogeneous morphologies in patients diagnosed with amyotrophic lateral sclerosis (ALS), pathological subclassification is routinely performed in the minority of patients with concomitant frontotemporal dementia (FTD)....

Descripción completa

Detalles Bibliográficos
Autores principales:	Tan, Rachel H., McCann, Heather, Shepherd, Claire E., Pinkerton, Monica, Mazumder, Srestha, Devenney, Emma M., Adler, Gabrielle L., Rowe, Dominic B., Kril, Jillian, Halliday, Glenda M., Kiernan, Matthew C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10642010/ https://www.ncbi.nlm.nih.gov/pubmed/37957721 http://dx.doi.org/10.1186/s40478-023-01670-2

Ejemplares similares

Riluzole is associated with decreasing neuritic plaque severity in amyotrophic lateral sclerosis
por: Mazumder, Srestha, et al.
Publicado: (2022)

Spread of pathology in amyotrophic lateral sclerosis: assessment of phosphorylated TDP-43 along axonal pathways
por: Fatima, Manaal, et al.
Publicado: (2015)

Phosphorylated TDP-43 (pTDP-43) aggregates in the axial skeletal muscle of patients with sporadic and familial amyotrophic lateral sclerosis
por: Cykowski, Matthew D., et al.
Publicado: (2018)

Functional connectivity changes resemble patterns of pTDP-43 pathology in amyotrophic lateral sclerosis
por: Schulthess, Ines, et al.
Publicado: (2016)

Classification of FTLD-TDP cases into pathological subtypes using antibodies against phosphorylated and non-phosphorylated TDP43
por: Tan, Rachel H, et al.
Publicado: (2013)

Atypical astroglial pTDP‐43 pathology in astroglial predominant tauopathy
por: Gelpi, Ellen, et al.
Publicado: (2021)

Eye Movement Deficits Are Consistent with a Staging Model of pTDP-43 Pathology in Amyotrophic Lateral Sclerosis
por: Gorges, Martin, et al.
Publicado: (2015)

Distinct TDP-43 inclusion morphologies in frontotemporal lobar degeneration with and without amyotrophic lateral sclerosis
por: Tan, Rachel H., et al.
Publicado: (2017)

The contribution of brain banks to knowledge discovery in amyotrophic lateral sclerosis: A systematic review
por: Mazumder, Srestha, et al.
Publicado: (2022)

HR23B pathology preferentially co-localizes with p62, pTDP-43 and poly-GA in C9ORF72-linked frontotemporal dementia and amyotrophic lateral sclerosis
por: Riemslagh, Frederike W., et al.
Publicado: (2019)

ATP-binding cassette transporter expression is widely dysregulated in frontotemporal dementia with TDP-43 inclusions
por: Katzeff, Jared S., et al.
Publicado: (2022)

pTDP‐43 aggregates accumulate in non‐central nervous system tissues prior to symptom onset in amyotrophic lateral sclerosis: a case series linking archival surgical biopsies with clinical phenotypic data
por: Pattle, Samuel B, et al.
Publicado: (2022)

TDP-43 and Phosphorylated TDP-43 Levels in Paired Plasma and CSF Samples in Amyotrophic Lateral Sclerosis
por: Ren, Yuting, et al.
Publicado: (2021)

Monomerization of TDP-43 is a key determinant for inducing TDP-43 pathology in amyotrophic lateral sclerosis
por: Oiwa, Kotaro, et al.
Publicado: (2023)

TDP-43—The key to understanding amyotrophic lateral sclerosis
por: Xu, Zuoshang, et al.
Publicado: (2014)

The role of TDP-43 mislocalization in amyotrophic lateral sclerosis
por: Suk, Terry R., et al.
Publicado: (2020)

Cytoplasmic Accumulation and Aggregation of TDP-43 upon Proteasome Inhibition in Cultured Neurons
por: van Eersel, Janet, et al.
Publicado: (2011)

TDP-43 protein variants as biomarkers in amyotrophic lateral sclerosis
por: Williams, Stephanie M., et al.
Publicado: (2017)

Clinical Significance of TDP-43 Neuropathology in Amyotrophic Lateral Sclerosis
por: Cykowski, Matthew D., et al.
Publicado: (2017)

TDP‐43 as structure‐based biomarker in amyotrophic lateral sclerosis
por: Beyer, Léon, et al.
Publicado: (2020)

Intracellular Conformation of Amyotrophic Lateral Sclerosis-Causative TDP-43
por: Kitamura, Akira, et al.
Publicado: (2023)

Multiple pathways of lipid dysregulation in amyotrophic lateral sclerosis
por: Phan, Katherine, et al.
Publicado: (2022)

Biomarker discovery and development for frontotemporal dementia and amyotrophic lateral sclerosis
por: Katzeff, Jared S., et al.
Publicado: (2022)

The RNA-binding motif 45 (RBM45) protein accumulates in inclusion bodies in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) patients
por: Collins, Mahlon, et al.
Publicado: (2012)

Elimination of TDP-43 inclusions linked to amyotrophic lateral sclerosis by a misfolding-specific intrabody with dual proteolytic signals
por: Tamaki, Yoshitaka, et al.
Publicado: (2018)

TDP-43 Is Not a Common Cause of Sporadic Amyotrophic Lateral Sclerosis
por: Guerreiro, Rita J., et al.
Publicado: (2008)

Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis
por: Prasad, Archana, et al.
Publicado: (2019)

TDP-43–specific Autoantibody Decline in Patients With Amyotrophic Lateral Sclerosis
por: Nielsen, Anne Kallehauge, et al.
Publicado: (2020)

TDP-43 and Inflammation: Implications for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
por: Bright, Fiona, et al.
Publicado: (2021)

Old age amyotrophic lateral sclerosis and limbic TDP‐43 pathology
por: Murakami, Aya, et al.
Publicado: (2022)

TDP-43 dysregulation and neuromuscular junction disruption in amyotrophic lateral sclerosis
por: Lépine, Sarah, et al.
Publicado: (2022)

TDP-43 proteinopathies: a new wave of neurodegenerative diseases
por: de Boer, Eva Maria Johanna, et al.
Publicado: (2021)

The pathogenic mechanism of TAR DNA-binding protein 43 (TDP-43) in amyotrophic lateral sclerosis
por: Wang, Xinxin, et al.
Publicado: (2023)

Short tandem repeat expansions in sporadic amyotrophic lateral sclerosis and frontotemporal dementia
por: Henden, Lyndal, et al.
Publicado: (2023)

Association Between TDP-43 and Mitochondria in Inclusion Body Myositis
por: Huntley, Mikayla L., et al.
Publicado: (2019)

Cerebellar Integrity in the Amyotrophic Lateral Sclerosis - Frontotemporal Dementia Continuum
por: Tan, Rachel H., et al.
Publicado: (2014)

Novel Mutations in TARDBP (TDP-43) in Patients with Familial Amyotrophic Lateral Sclerosis
por: Rutherford, Nicola J., et al.
Publicado: (2008)

Systemic dysregulation of TDP-43 binding microRNAs in amyotrophic lateral sclerosis
por: Freischmidt, Axel, et al.
Publicado: (2013)

TDP-43 pathology in the basal forebrain and hypothalamus of patients with amyotrophic lateral sclerosis
por: Cykowski, Matthew D, et al.
Publicado: (2014)

Mass spectrometric analysis of accumulated TDP-43 in amyotrophic lateral sclerosis brains
por: Kametani, Fuyuki, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_5ted2tjl0molc9sasji962fk67